| # | Side effect | Count |
|---|---|---|
| 0 | DYSPNOEA | 657 |
| 1 | PNEUMONIA | 556 |
| 2 | FATIGUE | 480 |
| 3 | HEADACHE | 426 |
| 4 | PRODUCT DOSE OMISSION ISSUE | 419 |
| 5 | DEATH | 336 |
| 6 | COUGH | 327 |
| 7 | INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION | 300 |
| 8 | MALAISE | 273 |
| 9 | COVID-19 | 241 |
| # | Side effect | Count | Frequency |
|---|---|---|---|
| 0 | ALPHA-1 ANTITRYPSIN DEFICIENCY | 17 | 0.1932 |
| 1 | ADENOVIRAL HEPATITIS | 11 | 0.0468 |
| 2 | OXYGEN SATURATION ABNORMAL | 62 | 0.0218 |
| 3 | INFUSION SITE BRUISING | 29 | 0.0134 |
| 4 | INSURANCE ISSUE | 190 | 0.0124 |
| 5 | VEIN RUPTURE | 19 | 0.0113 |
| 6 | POOR VENOUS ACCESS | 99 | 0.0096 |
| 7 | EPSTEIN-BARR VIRUS INFECTION REACTIVATION | 12 | 0.0091 |
| 8 | OBSTRUCTION | 34 | 0.0085 |
| 9 | INFUSION SITE EXTRAVASATION | 44 | 0.0071 |